Metabolic Consequences of Antiretroviral Therapy
Author:
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Link
https://link.springer.com/content/pdf/10.1007/s11904-022-00600-6.pdf
Reference110 articles.
1. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194(1):11–9. https://doi.org/10.1086/505147.
2. Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, et al. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS. 2002;16(18):2447–54. https://doi.org/10.1097/00002030-200212060-00010.
3. Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, et al. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288(2):207–15. https://doi.org/10.1001/jama.288.2.207.
4. van Vonderen MG, van Agtmael MA, Hassink EA, Milinkovic A, Brinkman K, Geerlings SE, et al. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. PLoS ONE. 2009;4(5): e5647. https://doi.org/10.1371/journal.pone.0005647.
5. Bogner JR, Vielhauer V, Beckmann RA, Michl G, Wille L, Salzberger B, et al. Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr. 2001;27(3):237–44. https://doi.org/10.1097/00126334-200107010-00004.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety profiles of dolutegravir plus lamivudine vs. bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1;Chinese Medical Journal;2023-11-02
2. Epidemiology of obesity among people with HIV;Current Opinion in HIV and AIDS;2023-11-02
3. Obesity among women with HIV;Current Opinion in HIV and AIDS;2023-11-01
4. The HIV patient in primary care;MMW - Fortschritte der Medizin;2023-10
5. Metabolic syndrome among people living with HIV in Ethiopia: a systematic review and meta-analysis;Diabetology & Metabolic Syndrome;2023-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3